Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer
Authors
Keywords
Small cell cancer (SCC), CDK7 inhibitor, Resistance, Targeted therapy
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 907, Issue -, Pages 174298
Publisher
Elsevier BV
Online
2021-07-03
DOI
10.1016/j.ejphar.2021.174298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Approaches to SCLC Therapy: From the Laboratory to the Clinic
- (2020) John T. Poirier et al. Journal of Thoracic Oncology
- CDK7 inhibitors as anticancer drugs
- (2020) Georgina P. Sava et al. CANCER AND METASTASIS REVIEWS
- CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
- (2020) Jian Wang et al. Journal of Hematology & Oncology
- Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure
- (2020) Peixin Chen et al. Translational Lung Cancer Research
- The role of immunotherapy in small cell lung cancer
- (2019) A. Calles et al. Clinical & Translational Oncology
- CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
- (2019) Hua Zhang et al. CANCER CELL
- Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
- (2018) Mei Zeng et al. eLife
- Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
- (2016) Paul A. Bunn et al. Journal of Thoracic Oncology
- Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline
- (2015) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- Inhibit Globally, Act Locally: CDK7 Inhibitors in Cancer Therapy
- (2014) Kaixiang Cao et al. CANCER CELL
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
- (2014) Camilla L. Christensen et al. CANCER CELL
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II
- (2012) S. G. Manzo et al. CANCER RESEARCH
- Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion
- (2012) Miguel Ganuza et al. EMBO JOURNAL
- Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
- (2012) Stéphane Larochelle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- TFIIH Kinase Places Bivalent Marks on the Carboxy-Terminal Domain of RNA Polymerase II
- (2009) Md. Sohail Akhtar et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation